Cyanobacteria-probiotics symbionts for modulation of intestinal inflammation and microbiome dysregulation in colitis.
Jiali Yang, Shaochong Tan, Shengchan Ge, Mingzhu Yang, Hua Liu, Wei Liu, Kaixiang Zhang, Zhenzhong Zhang, Zhi-Hao Wang, Jinjin Shi, Junjie Liu · Proceedings of the National Academy of Sciences of the United States of America · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In mice, 3 G, preincubation of cells with ASp@BS under dark conditions led to a reduction in intracellular ROS, indicating that ASp@BS can effectively defend against oxidative stress by generating H₂. Crucially, in contrast to conventional immunosuppressive agents, which are associated with adverse events such as opportunistic infections, autoimmune reactions, and hepatotoxicity, the authors' extensive investigation did not reveal any apparent toxicity related to repeated ASp@BS treatment, as evidenced in SI Appendix, Figs. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in mice. 3 G, preincubation of cells with ASp@BS under dark conditions led to a reduction in intracellular ROS, indicating that ASp@BS can effectively defend against oxidative stress by generating H₂.
What the Researchers Studied
The researchers studied mice. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
The H₂ production capability of ASp@BS was assessed using gas chromatograph and a Methylene Blue-Platinum (MB-Pt) probe. 3 G, preincubation of cells with ASp@BS under dark conditions led to a reduction in intracellular ROS, indicating that ASp@BS can effectively defend against oxidative stress by generating H₂. The authors concluded that the H₂ gas thus produced replaces conventional anti-inflammatory drugs, offering a distinct advantage owing to its capacity to efficiently neutralize ROS and subsequently mitigate inflammation.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.